Make Go/No-Go Decisions Earlier in Drug Development With In Vivo Fluorescence Imaging

Currently, about one in 10 drug candidates make it to the market with R&D costs of well over 1 billion USD per new drug. Being able to make early decisions to select drug candidates that have the most potential for clinical success or stop development of risky drug candidates is of paramount importance.

Watch this on demand webinar to learn how the use of NIR fluorescent probes and in vivo imaging approaches has greatly impacted drug development by providing early detection of disease processes, drug efficacy, and drug-induced tissue injury.